lobbying_activities: 1695765
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1695765 | 9e80cdad-bce8-4036-bed9-bd6ab0547c53 | Q2 | POLICY DIRECTIONS INC. | 31747 | ENTERA HEALTH, INC. | 2015 | second_quarter | MED | Guidance on Investigational New Drug; Overall industry standards | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-07-15T11:09:03.803000-04:00 |